BDBM50105683 (E)-N-Hydroxy-3-[4-(4-trifluoromethoxy-benzenesulfonylamino)-phenyl]-acrylamide::CHEMBL97384::N-hydroxy-3-(4-(4-(trifluoromethoxy)phenylsulfonamido)phenyl)acrylamide::US8796330, 112

SMILES ONC(=O)\C=C\c1ccc(NS(=O)(=O)c2ccc(OC(F)(F)F)cc2)cc1

InChI Key InChIKey=XKIRBCHKTVYWEY-UHFFFAOYSA-N

Data  3 IC50  1 EC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 4 hits for monomerid = 50105683   

TargetHistone deacetylase 1(Human)
Methylgene

US Patent
LigandPNGBDBM50105683(US8796330, 112 | CHEMBL97384 | (E)-N-Hydroxy-3-[4-...)
Affinity DataIC50: 600nMT: 2°CAssay Description:For deacetylase assays, 20,000 cpm of the [3H]-metabolically labeled acetylated histone substrate (M. Yoshida et al., J. Biol. Chem. 265(28): 17174-1...More data for this Ligand-Target Pair
In Depth
Date in BDB:
12/22/2014
Entry Details
Go to US Patent

TargetHistone deacetylase 1(Human)
Methylgene

US Patent
LigandPNGBDBM50105683(US8796330, 112 | CHEMBL97384 | (E)-N-Hydroxy-3-[4-...)
Affinity DataEC50:  2.00E+3nMAssay Description:Concentration of compound required for acetylation of histone-4 in human T24 cancer cellsMore data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetHistone deacetylase 1(Human)
Methylgene

US Patent
LigandPNGBDBM50105683(US8796330, 112 | CHEMBL97384 | (E)-N-Hydroxy-3-[4-...)
Affinity DataIC50: 600nMAssay Description:In vitro inhibition of partially purified recombinant human Histone deacetylase 1More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed
TargetHistone deacetylase 8(Human)TBA
LigandPNGBDBM50105683(US8796330, 112 | CHEMBL97384 | (E)-N-Hydroxy-3-[4-...)
Affinity DataIC50: 600nMAssay Description:Inhibition of Homo sapiens (human) HDAC8More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/30/2020
Entry Details Article